PL347058A1 - Streptococcal c beta protein compositions - Google Patents

Streptococcal c beta protein compositions

Info

Publication number
PL347058A1
PL347058A1 PL99347058A PL34705899A PL347058A1 PL 347058 A1 PL347058 A1 PL 347058A1 PL 99347058 A PL99347058 A PL 99347058A PL 34705899 A PL34705899 A PL 34705899A PL 347058 A1 PL347058 A1 PL 347058A1
Authority
PL
Poland
Prior art keywords
streptococcal
protein compositions
beta protein
beta
compositions
Prior art date
Application number
PL99347058A
Inventor
Karen O Long-Rowe
Milan S Blake
Original Assignee
North American Vaccine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North American Vaccine filed Critical North American Vaccine
Publication of PL347058A1 publication Critical patent/PL347058A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL99347058A 1998-09-17 1999-09-17 Streptococcal c beta protein compositions PL347058A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10085998P 1998-09-17 1998-09-17
US14432499P 1999-07-19 1999-07-19
US15401799P 1999-09-15 1999-09-15

Publications (1)

Publication Number Publication Date
PL347058A1 true PL347058A1 (en) 2002-03-11

Family

ID=27379089

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99347058A PL347058A1 (en) 1998-09-17 1999-09-17 Streptococcal c beta protein compositions

Country Status (10)

Country Link
EP (1) EP1114143A4 (en)
JP (1) JP2002525041A (en)
AU (1) AU6049599A (en)
CA (1) CA2343051A1 (en)
CZ (1) CZ2001951A3 (en)
HU (1) HUP0103502A2 (en)
NO (1) NO20011381D0 (en)
PL (1) PL347058A1 (en)
SK (1) SK3482001A3 (en)
WO (1) WO2000015760A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
JP2013537531A (en) 2010-08-04 2013-10-03 トーマス・ジュリアス・ボロディ Composition for faecal flora transplantation and methods for making and using it and device for delivering the same
AU2012225305B2 (en) 2011-03-09 2017-06-08 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
IN2014DN07752A (en) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
JP6868562B2 (en) 2014-10-31 2021-05-19 ペンデュラム セラピューティクス, インコーポレイテッド Methods and compositions for microbial treatment and diagnosis of disorders
KR102561989B1 (en) 2015-05-14 2023-07-31 핀치 테라퓨틱스 홀딩스 엘엘씨 Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
CN108243608A (en) 2015-05-22 2018-07-03 亚利桑那大学董事会 For treating autism spectrum disorder and related indication method
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3606541A1 (en) 2017-04-05 2020-02-12 Crestovo Holdings LLC Compositions and methods for treating parkinson's disease (pd) and related disorders
CA3064773A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
CN111328284A (en) 2017-08-07 2020-06-23 芬奇治疗公司 Compositions and methods for maintaining and restoring a healthy intestinal barrier
CA3073838A1 (en) 2017-08-30 2019-03-07 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
AU2019351017A1 (en) 2018-09-27 2021-04-29 Finch Therapeutics Holdings Llc. Compositions and methods for treating epilepsy and related disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757134A (en) * 1982-12-02 1988-07-12 The Rockefeller University IgA binding protein
US5595740A (en) * 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
WO1998009648A1 (en) * 1996-09-06 1998-03-12 North American Vaccine, Inc. NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS

Also Published As

Publication number Publication date
NO20011381L (en) 2001-03-19
CA2343051A1 (en) 2000-03-23
AU6049599A (en) 2000-04-03
WO2000015760A1 (en) 2000-03-23
NO20011381D0 (en) 2001-03-19
SK3482001A3 (en) 2002-02-05
JP2002525041A (en) 2002-08-13
HUP0103502A2 (en) 2002-01-28
EP1114143A1 (en) 2001-07-11
CZ2001951A3 (en) 2001-11-14
EP1114143A4 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
PL347058A1 (en) Streptococcal c beta protein compositions
EP1113799A4 (en) Protein formulations
AP2000001874A0 (en) Cellecoxib compositions
GB9811377D0 (en) Compositions
EP1110969A4 (en) Interleukin 18-binding protein
HK1026151A1 (en) Stabilized protein compositions
HK1039158A1 (en) Nlk1-interacting proteins
PL344979A1 (en) Angiostatin-binding protein
IL137497A0 (en) Placental protein 13
IL143052A0 (en) Mammalian chondromodulin-like protein
GB2339693B (en) Anti-mollusc compositions
GB9805782D0 (en) Compositions
GB9816337D0 (en) Proteins
GB9828704D0 (en) Proteins
GB0016470D0 (en) Compositions
GB9806810D0 (en) Compositions
GB9828880D0 (en) Protein
GB2336535B (en) Compositions
GB9809347D0 (en) Compositions
GB9809566D0 (en) Protein
GB9819038D0 (en) Protein
GB9812607D0 (en) Protein
GB9816335D0 (en) Proteins
GB0315759D0 (en) Proteins
EP1144442A3 (en) Streptococcal alpha2m-binding protein

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)